Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study

Multiple Sclerosis

Volumn 21, Issue 14, 2015, Pages 1856-1864

  Cortese, Marianna ^a,b   Riise, Trond ^a,c   Bjørnevik, Kjetil ^a,b   Holmøy, Trygve ^d,e   Kampman, Margitta T ^f,g   Magalhaes, Sandra ^a,g,h   Pugliatti, Maura ^g,i   Wolfson, Christina ^g   Myhr, Kjell Morten ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF SASSARI   (Italy)

ⁱ MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

age; cod liver oil; environmental risk factors; Multiple sclerosis; supplementation; susceptibility; timing; vitamin D

Indexed keywords

COD LIVER OIL; VITAMIN D; COLECALCIFEROL;

ADOLESCENT; ADULT; ARTICLE; BODY SIZE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EDUCATION; FAT INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; RISK REDUCTION; SEASONAL VARIATION; SMOKING; SUN EXPOSURE; TIME TO TREATMENT; TREATMENT DURATION; VITAMIN INTAKE; BODY MASS; DIETARY REFERENCE INTAKE; DISEASE DURATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; MIDDLE AGED; OUTCOME ASSESSMENT; QUESTIONNAIRE; RISK FACTOR; VITAMIN SUPPLEMENTATION; YOUNG ADULT; AGE; DIETARY SUPPLEMENT; DOSE RESPONSE; NORWAY; REGISTER; RISK;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CHOLECALCIFEROL; COD LIVER OIL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NORWAY; REGISTRIES; RISK; YOUNG ADULT;

EID: 84948137103     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515578770     Document Type: Article

References (38)

1. Ascherio A, Munger KL, Lunemann JD,. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012; 8: 602-612.
2. Handel AE, Giovannoni G, Ebers GC, et al. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010; 6: 156-166.
3. Islam T, Gauderman WJ, Cozen W, et al. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 2007; 69: 381-388.
4. Kampman MT, Wilsgaard T, Mellgren SI,. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 2007; 254: 471-477.
5. van der Mei IA, Ponsonby AL, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study. BMJ 2003; 327: 316.
6. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60-65.
7. Pugliatti M, Riise T, Sotgiu MA, et al. Evidence of early childhood as the susceptibility period in multiple sclerosis: Space-time cluster analysis in a Sardinian population. Am J Epidemiol 2006; 164: 326-333.
8. Riise T, Gronning M, Klauber MR, et al. Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway. Am J Epidemiol 1991; 133: 932-939.
9. Hammond SR, English DR, McLeod JG,. The age-range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia. Brain 2000; 123 (Pt 5): 968-974.
10. Gale CR, Martyn CN,. Migrant studies in multiple sclerosis. Prog Neurobiol 1995; 47: 425-448.
11. Staples J, Ponsonby AL, Lim L,. Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: Longitudinal analysis. BMJ 2010; 340: c1640.
12. Mirzaei F, Michels KB, Munger K, et al. Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol 2011; 70: 30-40.
13. Munger KL, Soilu-Hänninen M, Åivo J, et al. In utero 25-hydroxyvitamin D and risk of multiple sclerosis among offspring in the Finnish Maternity Cohort. 2014 Joint ACTRIMS-ECTRIMS Meeting Poster Session 1, Boston, USA. Mult Scler 2014; 20: 67-284, Poster no. P330.
14. Engelsen O, Brustad M, Aksnes L, et al. Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol 2005; 81: 1287-1290.
15. Birgisdottir BE, Brantsaeter AL, Kvalem HE, et al. Fish liver and seagull eggs, vitamin D-rich foods with a shadow: Results from the Norwegian Fish and Game Study. Mol Nutr Food Res 2012; 56: 388-398.
16. Alexander J, Frøyland L, Hemre G-I, et al. A comprehensive assessment of fish and other seafood in the Norwegian diet. The Norwegian Scientific Committee for Food Safety (VKM), http://www.vkm.no/dav/d94dff429b.pdf (2006,. accessed 20 April 2015).
17. Pugliatti M, Casetta I, Drulovic J, et al. A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q). Acta Neurol Scand Suppl 2012: 43-50.
18. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteriaâ€. Ann Neurol 2005; 58: 840-846.
19. Myhr KM, Grytten N, Aarseth JH,. The Norwegian Multiple Sclerosis Registry and Biobank. Acta Neurol Scand Suppl 2012: 20-23.
20. Johansson LR, Solvoll K, Bjørneboe GE, et al. Intake of very-long-chain n-3 fatty acids related to social status and lifestyle. Eur J Clin Nutr 1998; 52: 716-721.
21. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838.
22. Stunkard AJ, Sørensen T, Schulsinger F,. Use of the Danish Adoption Register for the study of obesity and thinness. Res Publ Assoc Res Nerv Ment Dis 1983; 60: 115-120.
23. Stunkard A,. Old and new scales for the assessment of body image. Percept Mot Skills 2000; 90: 930.
24. Munger KL, Chitnis T, Ascherio A,. Body size and risk of MS in two cohorts of US women. Neurology 2009; 73: 1543-1550.
25. Adzemovic MZ, Zeitelhofer M, Hochmeister S, et al. Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage. Exp Neurol 2013; 249: 39-48.
26. Hernan MA, Zhang SM, Lipworth L, et al. Multiple sclerosis and age at infection with common viruses. Epidemiology 2001; 12: 301-306.
27. Hedström AK, Åkerstedt T, Hillert J, et al. Shift work at young age is associated with increased risk for multiple sclerosis. Ann Neurol 2011; 70: 733-741.
28. Bjørnevik K, Riise T, Casetta I, et al. Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study. Mult Scler 2014; 20: 1042-1049.
29. Munger KL, Chitnis T, Frazier AL, et al. Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. J Neurol 2011; 258: 479-485.
30. Correale J, Ysrraelit MC, Gaitan MI,. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009; 132: 1146-1160.
31. Torkildsen O, Wergeland S, Bakke S, et al. Omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): A randomized, double-blind, placebo-controlled trial. Arch Neurol 2012; 69: 1044-1051.
32. Løken-Amsrud KI, Myhr KM, Bakke SJ, et al. Alpha-tocopherol and MRI outcomes in multiple sclerosis-association and prediction. PLoS One 2013; 8: e54417.
33. Løken-Amsrud KI, Myhr KM, Bakke SJ, et al. Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult Scler 2013; 19: 451-457.
34. Salzer J, Hallmans G, Nyström M, et al. Vitamin A and systemic inflammation as protective factors in multiple sclerosis. Mult Scler 2013; 19: 1046-1051.
35. Zhang SM, Willett WC, Hernan MA, et al. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 2000; 152: 1056-1064.
36. Zhang SM, Hernan MA, Olek MJ, et al. Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women. Neurology 2001; 57: 75-80.
37. Swank RL, Lerstad O, Strøm A, et al. Multiple sclerosis in rural Norway-its geographic and occupational incidence in relation to nutrition. N Engl J Med 1952; 246: 722-728.
38. Bäärnhielm M, Olsson T, Alfredsson L,. Fatty fish intake is associated with decreased occurrence of multiple sclerosis. Mult Scler 2014; 20: 726-732.